Trends in Genetic Testing for Alzheimer’s
May 12, 2023With the approval of new drugs by Eisai and Biogen, genetic testing for Alzheimer’s is on the rise. This article… Read More
Tags: Alzheimers, Genetic Testing, Life Insurance, Underwriting
Alzheimers
Welcome to the CRL Insurer Services blog! Here you will find commentary from our dedicated team of medical directors and industry leaders on lab research and trends, innovative services and solutions, and what’s new at CRL. Click the button below to get the latest news directly to your inbox. Questions? Contact us at ILSsales@crlcorp.com.
Alzheimer’s Dementia Onset: Study Examines the Impact of Lifestyle Factors on Life Expectancy
August 25, 2022A Note from Dr. Robert Stout, CRL Chief Scientific Officer & Co-Founder The below commentary from Michael Fulks, MD, is… Read More
Tags: Alzheimers, Cardiovascular risk, Dementia, Life expectancy, Life Insurance
Treatment Updates for Alzheimer’s Disease: Some Hope for Prevention
October 1, 2021Dr. Michael Fulks comments on the results of a recent study of Donanemab, an antibody that targets the amyloid-β (Aβ)… Read More
Tags: Alzheimers, Cardiovascular, Dementia, Risk
Dementia: Causes, Risks, and Potential Prevention
February 18, 2020Dr. Michael Fulks is a Medical Director for Clinical Reference Laboratory (CRL). He is an expert commentator on core issues… Read More
Tags: Alzheimers, Cardiovascular Disease, Dementia, Life Insurance, Underwriting
If you would like to sign up to receive email updates from the Insurer team, please click here.